PCOS Diagnostic Market Size and Growth Report till 2028

Summary

Report Description

Global PCOS Diagnostic Market is expected to grow at steady rate over the forecast period. The growing prevalence of polycystic ovarian syndrome will support the global Polycystic Ovarian Syndrome Diagnostic market, as the increased cases of PCOS will elevate the demand for the effective diagnostic procedures and medications, thus benefitting the market positively. The growing PCOS occurrence, increased demand for early diagnosis, extended sedentary lifestyle and obesity among the women of reproductive age will help the polycystic ovarian syndrome (PCOS) diagnostic market to grow significantly around the globe.

Polycystic Ovarian Syndrome (PCOS) is a condition arising due to hormonal imbalance affecting the women of childbearing age. It is a symptomatic disorder characterized by irregular or no-periods, and increased levels of male hormones in the body. According to the Centers for Disease Control and Prevention, approximately 5 million women of reproductive age in the United States have polycystic ovarian syndrome. The rise in cases will hence directly offer opportunities for the PCOS diagnostic market to grow significantly over the forecast period.

Rising Prevalence of PCOS Among Females of Reproductive Age

Globally, PCOS affects over 6% -10% of women in the reproductive age. According to the Global Burden of Disease study, in 2017, prevalence as well as severity of problems among women of age 15-49 years accounted for 1.55 million (95% uncertainty intervals) incident cases of PCOS. In the year 2007 and 2017,the highest age standardized incidences and disease occurrence rate was observed in Ecuador, Peru, Bolivia, Japan, and Bermuda .

Also, the highest prevalence of PCOS is found to be among the women in UAE and is a leading cause of infertility in the country. Similarly, according to a research study performed by Texas Woman’s University to record prevalence of PCOS based on the diagnosis method, it was observed that 28.5% of the PCOS prevalence was indicated for formal diagnosed PCOS respondents, and a larger account of prevalence i.e., around 40.5% was indicated among those women without a formal diagnosis.

Sedentary Lifestyle and Increasing Cases of Obesity Among the Population

The increasing rate of occurrence of obesity among women has almost doubled i.e., from 6% -10% around the globe. A study revealed that there is an odd ratio of 2.77 for the development of PCOS among obese women and their non-obese women counterparts. Similarly, According to ClinicalTrials.Gov results based on a study conducted among women in Spain, it was observed that there were ~28.3% more chances of PCOS in obese women, compared to 5.5% prevalence of PCOS among the healthy weighted women. Sedentary lifestyle is the most common cause for PCOS and is therefore observed most in younger generation among the urban population due to increased bad eating habits and inactive lifestyle adaptation such as no physical exercise and excessive stress. This aspect is propelling the PCOS diagnostic market for higher demand, across the globe.

Increase in Demand for Early Diagnosis For PCOS

Since PCOS has been associated with a higher chance of acquiring several illnesses, such as insulin resistance, type 2 diabetes, high cholesterol, high blood pressure, heart disease, miscarriage or premature birth, depression, anxiety, bleeding from the uterus, etc., therefore, early detection of the condition is highly crucial.

According to a research study published in Environmental Research and Public health journal, PCOS has a very high percentage of individuals who remained undiagnosed when visiting their doctor, which is a number estimated to be as high as 75%. The symptoms linked to excess androgen and abnormalities in periods have a significant negative impact on women's quality of life. Therefore, in order to avoid the problem from getting worse, the patient should consult a doctor about their symptoms and possibly pursue further testing to avoid complications. Adolescent PCOS is a growing health concern, thus, the early interventions and the encouragement of healthy lifestyles are required to prevent additional morbidities. In accordance with the diagnosis, the doctor may advise the patient to use hormonal birth control pills to reduce the risk of endometrial instances, regulating the period, treating skin acne, and reducing excess body hair.

Recent Developments

PCOS Awareness Month (1September - 30 September)

PCOS awareness month is a federally designated event, which is organized in the September month and inaugurated as an initiative for spreading awareness and support among women suffering from PCOS. The National Polycystic Ovary Syndrome Association is sponsoring the largest non- profit support and advocacy organization PCOS Challenge, established to provide support to people with polycystic ovarian syndrome. It is serving over 55,000 members across the globe. This non-profit organization is supporting PCOS affected individuals each year through several television and radio programming, online and offline support groups, education, grants, awareness and advocacy initiatives. By increasing awareness & education about PCOS among the general public, girls, and women, they provide information on diagnosis and treatment options, thereby promoting the need for early diagnosis.

Download Free Sample Report

Market Segmentation

Global PCOS Diagnosis market can be segmented based on the test type, end user and region. Based on the test type, the market can be segmented into Blood test, pelvic exam and Transvaginal ultrasound. Depending on the end user, the market can be segmented into Hospitals & Clinics, Fertility Clinics and Others.

Market Players

Siemens Healthineers AG, GE Healthcare, Mindray Medical International Limited, Esaote S.p.A, Telemed Medical Systems, Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI), BK Medical, Alpinion Medical Systems, Mindray ZONARE Medical Systems, Xianfeng Ultrasound Medical are some of the leading companies operating in the market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2023 and 2024-2028
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Test Type End User Region
Regional scope	North America, Europe, Asia Pacific, South America, and Middle East & Africa
Key companies profiled	Siemens Healthineers AG, GE Healthcare, Mindray Medical International Limited, Esaote S.p.A, Telemed Medical Systems, Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI), BK Medical, Alpinion Medical Systems, Mindray ZONARE Medical Systems, Xianfeng Ultrasound Medical.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global PCOS Diagnostic Market, market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· PCOS Diagnostic Market, By Test Type:

o Blood tests

o Pelvic exam

o Ultrasound (Transvaginal)

· PCOS Diagnostic Market, By End User:

o Hospitals & Clinics

o Fertility clinics

o Others

· PCOS Diagnostic Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ Germany

§ France

§ Italy

§ Spain

o Asia Pacific

§ China

§ Japan

§ India

§ South Korea

§ Australia

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ UAE

§ Saudi Arabia

§ South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global PCOS Diagnostic Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

PCOS Diagnostic Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

5.1. Ongoing Clinical Trials

5.2. Completed Clinical Trials

5.3. Terminated Clinical Trials

5.4. Breakdown of Pipeline, By Development Phase

5.5. Breakdown of Pipeline, By Status

5.6. Breakdown of Pipeline, By Study Application

5.7. Breakdown of Pipeline, By Region

5.8. Clinical Trials Heat Map

6. Global PCOS Diagnosis Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Test Type (Blood test, Pelvic exam, Transvaginal Ultrasound)

6.2.2. By End Users (Hospitals & Clinics, Fertility Clinics, Others)

6.2.3. By Region

6.2.4. By Company (2022)

6.3. Product Market Map

6.3.1. By Test Type

6.3.2. By End Users

6.3.3. By Region

7. North America PCOS Diagnosis Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Test Type

7.2.2. By End Users

7.2.3. By Country

7.3. North America: Country Analysis

7.3.1. United States PCOS Diagnosis Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Test Type

7.3.1.2.2. By End Users

7.3.2. Mexico PCOS Diagnosis Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Test Type

7.3.2.2.2. By End Users

7.3.3. Canada PCOS Diagnosis Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Test Type

7.3.3.2.2. By End Users

8. Europe PCOS Diagnosis Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Test Type

8.2.2. By End Users

8.2.3. By Country

8.3. Europe: Country Analysis

8.3.1. France PCOS Diagnosis Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Test Type

8.3.1.2.2. By End Users

8.3.2. Germany PCOS Diagnosis Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Test Type

8.3.2.2.2. By End Users

8.3.3. United Kingdom PCOS Diagnosis Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Test Type

8.3.3.2.2. By End Users

8.3.4. Italy PCOS Diagnosis Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Test Type

8.3.4.2.2. By End Users

8.3.5. Spain PCOS Diagnosis Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Test Type

8.3.5.2.2. By End Users

9. Asia-Pacific PCOS Diagnosis Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Test Type

9.2.2. By End Users

9.2.3. By Country

9.3. Asia-Pacific: Country Analysis

9.3.1. China PCOS Diagnosis Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Test Type

9.3.1.2.2. By End Users

9.3.2. India PCOS Diagnosis Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Test Type

9.3.2.2.2. By End Users

9.3.3. South Korea PCOS Diagnosis Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Test Type

9.3.3.2.2. By End Users

9.3.4. Japan PCOS Diagnosis Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Test Type

9.3.4.2.2. By End Users

9.3.5. Australia PCOS Diagnosis Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Test Type

9.3.5.2.2. By End Users

10. South America PCOS Diagnosis Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Test Type

10.2.2. By End Users

10.2.3. By Country

10.3. South America: Country Analysis

10.3.1. Brazil PCOS Diagnosis Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Test Type

10.3.1.2.2. By End Users

10.3.2. Argentina PCOS Diagnosis Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Test Type

10.3.2.2.2. By End Users

10.3.3. Colombia PCOS Diagnosis Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Test Type

10.3.3.2.2. By End Users

11. Middle East and Africa PCOS Diagnosis Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Test Type

11.2.2. By End Users

11.2.3. By Country

11.3. MEA: Country Analysis

11.3.1. South Africa PCOS Diagnosis Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Test Type

11.3.1.2.2. By End Users

11.3.2. Saudi Arabia PCOS Diagnosis Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Test Type

11.3.2.2.2. By End Users

11.3.3. UAE PCOS Diagnosis Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Test Type

11.3.3.2.2. By End Users

11.3.4. Kuwait PCOS Diagnosis Market Outlook

11.3.4.1. Market Size & Forecast

11.3.4.1.1. By Value

11.3.4.2. Market Share & Forecast

11.3.4.2.1. By Test Type

11.3.4.2.2. By End Users

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

13.1. Recent Developments

13.2. Mergers & Acquisitions

13.3. Product Launches

14. Competitive Landscape

14.1. Business Overview

14.2. Company Snapshot

14.3. Products & Services

14.4. Financials (In Case of Listed Companies)

14.5. Recent Developments

14.6. SWOT Analysis

14.6.1. Siemens Healthineers AG

14.6.2. GE Healthcare

14.6.3. Mindray Medical International Limited

14.6.4. Esaote S.p.A

14.6.5. Telemed Medical Systems

14.6.6. Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)

14.6.7. BK Medical

14.6.8. Alpinion Medical Systems

14.6.9. Mindray ZONARE Medical Systems

14.6.10. Xianfeng Ultrasound Medical

Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major factors driving the Global PCOS Diagnostic Market growth, in 2028?

Growing sedentary lifestyle, increasing cases of obesity and stress leading to increasing prevalence of PCOS across the globe are the major factors propelling the growth of the global PCOS Diagnostic Market in 2028.

What are the most acceptable diagnostic tests for PCOS confirmation?

Though blood test, pelvic examination and pelvic ultrasound are the common acceptable diagnostic tests performed in the recent times, ultrasound is the most prioritized diagnostic method among the other PCOS confirming tests.

Who are the top players operating in the Global PCOS Diagnostic Market, market?

Which country has the Highest PCOS occurrence rate in the world?

North America holds the highest rank in the PCOS Diagnosis market in 2018 and is expected to lead in the forecast period. This is attributed to the highest PCOS prevalence across the globe, higher healthcare awareness and well-developed healthcare infrastructure.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

PCOS Diagnostic Market to be Dominated by the Transvaginal Ultrasound Segment by 2028

Jan, 2023

Increasing prevalence of PCOS among women is expected to drive Global PCOS Diagnostic Market in the forecast period, 2024-2028.

PCOS Diagnostic Market Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Test Type (Pelvic Exam, Blood Test, Transvaginal Ultrasound), By End User (Hospitals & Clinics, Fertility Clinics, Others), By Region and Competition

Buy Now